Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Acutus Medical Inc (AFIB)
Acutus Medical Inc (AFIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Acutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass Estimates Zacks - Thu Mar 16, 4:25PM CDT

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 158.57% and 3.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

AFIB : 0.6950 (-6.33%)
INFI : 0.1900 (-1.30%)
Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates Zacks - Thu Nov 10, 2022

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 13.25% and 3.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

AFIB : 0.6950 (-6.33%)
MTEM : 0.3346 (+0.94%)
Lyell Immunopharma (LYEL) Reports Q3 Loss, Lags Revenue Estimates Zacks - Tue Nov 8, 2022

Lyell Immunopharma (LYEL) delivered earnings and revenue surprises of 17.65% and 99.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LYEL : 2.34 (+5.41%)
AFIB : 0.6950 (-6.33%)
Corcept Therapeutics (CORT) Tops Q3 Earnings Estimates Zacks - Thu Nov 3, 2022

Corcept (CORT) delivered earnings and revenue surprises of 30.43% and 5.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CORT : 21.77 (-0.37%)
AFIB : 0.6950 (-6.33%)
SHAREHOLDER UPDATE: Glancy Prongay & Murray LLP Appointed Lead Counsel in Securities Class Action Against Acutus Medical, Inc. Business Wire - Wed Aug 24, 2022

Glancy Prongay & Murray LLP (“GPM”) announces that it has been appointed Lead Counsel in the securities class action against Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB...

AFIB : 0.6950 (-6.33%)
Acutus Medical, Inc. (AFIB) Q2 2022 Earnings Call Transcript Motley Fool - Fri Aug 12, 2022

AFIB earnings call for the period ending June 30, 2022.

AFIB : 0.6950 (-6.33%)
Amneal Pharmaceuticals (AMRX) Lags Q2 Earnings Estimates Zacks - Fri Aug 5, 2022

Amneal (AMRX) delivered earnings and revenue surprises of -5% and 4.63%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AMRX : 1.3100 (+3.15%)
AFIB : 0.6950 (-6.33%)
Akebia Therapeutics (AKBA) Surpasses Q2 Earnings and Revenue Estimates Zacks - Thu Aug 4, 2022

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of 174.19% and 158.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AKBA : 0.6050 (+0.95%)
AFIB : 0.6950 (-6.33%)
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Tue Aug 2, 2022

CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company...

AFIB : 0.6950 (-6.33%)
Acutus Medical to Announce Second Quarter 2022 Financial Results Globe Newswire - Thu Jul 28, 2022

CARLSBAD, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving...

AFIB : 0.6950 (-6.33%)

Barchart Exclusives

The X-Factor that Could Trigger a Gold Boom in the 2nd Half of 2023 Barchart - Wed Mar 29, 5:15PM CDT
Gold prices jumped to $2,000 last week in the wake of the collapse of Silicon Valley Bank. However, this could be just the start of a higher move for the precious metal. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot